94 reports

  • GLAXOSMITHKLINE

It is involved in discovering, developing, manufacturing, and commercializing prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases globally.

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

INFECTION, NEUROSCIENCE, AND GASTROINTESTINAL RESPIRATORY, INFLAMMATION, AND AUTOIMMUNITY In FY2014, this segment generated $##. ## billion, which was ##. ##% higher than the segment' s revenue in FY2013.

  • Allergy Drug
  • Respiratory Disease
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Sanofi S.A.

It designs manufactures, and markets endoscopy devices endoscopic video imaging systems; gastrointestinal, colon, duodenal, and broncho endoscopes, endoscopic ultrasound systems, ultrasound endoscopes and probes, ultrasound imaging systems, capsule endoscopy systems, sterilization systems m

  • Respiratory Disease
  • Boston Scientific Corporation
  • Broncus Medical Inc.
  • Medtronic, Inc.
  • Olympus Corporation
  • SAFETY OF STIOLTO RESPIMAT

THE COMPANY' S OVERALL PHARMACEUTICAL PORTFOLIO COVERS A VARIETY OF THERAPEUTIC AREAS, INCLUDING CV AND METABOLIC DISORDERS, NEUROSCIENCE, GASTROINTESTINAL DISORDERS, ONCOLOGY, RESPIRATORY, AND INFECTIOUS DISEASES.

  • Respiratory Disease
  • Demand
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.
  • ASTRAZENECA: BUSINESS SEGMENTATION BY REVENUE 2013 AND 2014

gastrointestinal diseases.

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Pipeline Landscape Assessment
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, OVERALL PHARMACEUTICAL INDUSTRY
  • Respiratory Disease
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC

gastrointestinal diseases.

  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Key vendor analysis

gastrointestinal diseases.

  • Asthma
  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.

gastrointestinal, and neuroscience diseases worldwide.

  • Respiratory Disease
  • World
  • Forecast
  • GlaxoSmithKline plc
  • Sanofi S.A.

It is a global biopharmaceutical company that focuses on the following segments: respiratory, inflammation and autoimmunity, cardiovascular and metabolic diseases, oncology, infection, neuroscience, and gastrointestinal disorders.

  • Allergy Drug
  • Respiratory Disease
  • Forecast
  • Novartis AG
  • Sanofi S.A.
  • EUROPE OXYGEN THERAPY EQUIPMENT MARKET

DISEASES COVERED UNDER SUCH PROGRAMS INCLUDE MOST CARDIOVASCULAR & GASTROINTESTINAL DISORDERS, ASTHMA, BREAST CANCER, CHRONIC-OBSTRUCTIVE PULMONARY DISEASE, CORONARY HEART DISEASE & HEART FAILURE, DIABETES ETC.

  • Respiratory Disease
  • World
  • Inogen, Inc.
  • Invacare Corporation
  • Philips Respironics, Inc.
  • Pharmaceutical Market, Global, Developmental
  • Asthma Therapeutics Market, Global, Co-Development Deals Valued Above $100m, 2006-2016
  • Respiratory Disease
  • World
  • Almirall, S.A.
  • Genentech, Inc.
  • Novartis AG
  • ASTRAZENECA REVENUE BY THERAPEUTIC SEGMENT (2013/2014)
  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG

gastrointestinal diseases.

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

MERGER AND ACQUISITION ASTRA ZENECA (2015) FIGURE ##: ASTRA ZENECA REVENUE BY SEGMENTS CARDIOVASCULAR & METABOLIC DISEASES ONCOLOGY RESPIRATORY, INFLAMMATION AND AUTOIMMUNITY INFECTION, NEUROSCIENCE AND GASTROINTESTINAL ##% ##% ##% ##% (2015) FIGURE ##: ASTRA ZENECA REVENUE, BY RESPIR

  • Respiratory Disease
  • World
  • Market Size
  • Astra Group
  • Becton Property Group

Daxas was the first, and remains the only, oral PDE## inhibitor available in the COPD market; however, uptake has been hindered due to the high frequency of gastrointestinal side effects.

  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • 9 Appendix

gastrointestinal, immunology and respiratory diseases Small molecules for asthma and COPD Small molecules for asthma and allergic rhinitis Small molecules for asthma and inflammation Soluble Beta glucan SPL-## Metabolab University of California Small molecule Small molecule channel protein

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG

Discovers, develops, and commercializes prescription medicines for the cardiovascular, gastrointestinal, neuroscience, oncology, respiratory, and inflammation AEROGEN AIRON ASTRAZENECA Description DEVILBISS HEALTHCARE BRIGGS HEALTHCARE BOEHRINGER INGELHEIM areas.

  • Respiratory Disease
  • Bespak plc
  • Consort Medical plc
  • Gerresheimer AG
  • Nypro Inc.

THEY PROVIDE INNOVATIVE, EFFECTIVE PRESCRIPTION MEDICINES IN SEVERAL IMPORTANT AREAS OF MEDICAL NEED: GASTROINTESTINAL, CARDIOVASCULAR, ONCOLOGY, NEUROSCIENCE, ANESTHESIA, INFECTION, RESPIRATORY & INFLAMMATION.

  • Pharmaceutical
  • Respiratory Disease
  • China
  • Supply
  • Zhejiang Expressway Co., Ltd.
  • Target

GASTROINTESTINAL SYSTEM IN SEVERELY ILL PATIENTS GDCT## EUDRACT-2011-002093-##, RESPIRATORY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), ILEUS (INTESTINAL OBSTRUCTION), LUNG INFECTIONS, PANCREATITIS, PERITONITIS, PNEUMONIA, UNSPECIFIED GASTROINTESTINAL DISORDERS COMPLETED PHA

  • Hospital
  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc

The presented data includes findings from Qu Biologics' randomized, controlled trial in Crohn' s disease for their lead immunomodulatory product, QBECO, which targets the gastrointestinal tract, as well as preclinical data for QBKPN, which restores innate immune function in the lun

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc

They provide innovative, effective prescription medicines in several important areas of medical need: gastrointestinal, cardiovascular, oncology, neuroscience, anesthesia, infection, respiratory & inflammation.

  • Respiratory Disease
  • China
  • AstraZeneca Pharmaceutical Co., Ltd
  • GlaxoSmithKline plc
  • Zhejiang Expressway Co., Ltd.

Gastrointestinal Disease.

  • Respiratory Disease
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

Gastrointestinal System in Severely Ill Patients GDCT## EudraCT-2011-002093-##, Respiratory Chronic Obstructive Pulmonary Disease (COPD), Ileus (Intestinal Obstruction), Lung Infections, Other Gastrointestinal Disorders, Pancreatitis, Peritonitis, Pneumonia Completed Phase IV

  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • Vernalis Plc
  • Products under Development by Universities/Institutes, H2 2017
  • Respiratory Disease
  • United States
  • World
  • Product Initiative
  • Vernalis plc
  • STEM CELL THERAPY FOR METABOLIC, GASTROINTESTINAL, MULTIPLE ORGAN FAILURE AND RESPIRATORY DISORDERS - DRUG PROFILE
  • ACUTE LUNG INJURY - PIPELINE BY S-EVANS BIOSCIENCES INC, H2 2016
  • Chronic Disease
  • Respiratory Disease
  • United States
  • World
  • Product Initiative

Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders.

  • Respiratory Disease
  • Japan
  • United States
  • Company
  • Kyowa Hakko Kirin Co., Ltd.

Results from the Phase I/ II study were presented at the 2017 Gastrointestinal Cancers Symposium.

  • Antibiotic Resistance
  • Respiratory Disease
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company
  • STEM CELL THERAPY FOR METABOLIC, GASTROINTESTINAL AND RESPIRATORY DISORDERS - DRUG PROFILE
  • ACUTE LUNG INJURY - PIPELINE BY S-EVANS BIOSCIENCES, INC., H1 2016
  • Chronic Disease
  • Respiratory Disease
  • Stem Cell Therapy
  • Therapy
  • Discovery Laboratories, Inc.
  • PERENNIAL ALLERGIC RHINITIS - PIPELINE BY PFIZER INC., H2 2016
  • Perennial Allergic Rhinitis - Companies Involved in Therapeutics Development

It offers products for the treatment of respiratory, cardiovascular and metabolic diseases and conditions, infection, inflammation, cancer, ophthalmic diseases, neurological problems, pain, tissue repair, gastrointestinal diseases, women' s health issues, orphan diseases and genitourina

  • Allergy Drug
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Pfizer Inc.